GlassScriptPhysician profile
Satish C Chada
NPI 1215915558
$18,245.78
in general payments reported to CMS, 2019-2025
44 companies · $2,820 in 2025
The $2,820 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,369 · 2020: $1,594 · 2021: $2,409 · 2022: $3,247 · 2023: $2,902 · 2024: $2,905 · 2025: $2,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,448 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,448.28 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,724.77 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,504.34 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Mylan Specialty L.P. | $1,488.83 | 2019-2024 | Yupelri |
| Genzyme Corporation | $1,409.12 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,046.37 | 2019-2025 | Ofev, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $984.88 | 2019-2025 | Dupixent |
| Philips North America LLC | $827.29 | 2019-2025 | Vest Therapy Und, (5091) Amd Und, (Bo0) Hosp Vent Devices |
| Actelion Pharmaceuticals US, INC. | $818.18 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $582.57 | 2022-2025 | Tezspire |
| United Therapeutics Corporation | $452.68 | 2020-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $422.96 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $364.44 | 2019-2025 | Winrevair |
| Baxter Healthcare | $299.11 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $286.16 | 2019-2025 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $273.94 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Chada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.